Karo Pharma AB - Company Profile
Powered by
All the data and insights you need on Karo Pharma AB in one report.
$295
- Save hours of research time and resources with
our up-to-date Karo Pharma AB Strategy Report
- Understand Karo Pharma AB position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Karo Pharma AB’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
28 Mar 2022 | Karo Pharma Acquires Assets of Del Decus Enterprises | Asset Transaction |
Sylphar NV
Karo Pharma AB |
Del Decus Enterprises Ltd.
|
24 Dec 2021 | Karo Pharma Acquires E45 Brand from Reckitt | Asset Transaction |
Karo Pharma AB
|
Reckitt Benckiser Group Plc |
22 Nov 2021 | Karo Pharma Acquires Sylphar from Vendis Capital | Acquisition |
Karo Pharma AB
|
Sylphar NV
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer